Search Within

Terence John Purdon

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (15)
  2. Journal Article (9)
Groups
  1. Adult Leukemia (24)
  2. Center for Hematologic Malignancies (24)
  3. Department of Medicine (24)
  4. GSK Faculty (24)
  5. Hematologic Malignancies Research (24)
  6. Hematologic Malignancies, Division of (24)

More Groups

People
  1. Renier Brentjens (23)
  2. Sarwish Rafiq (10)
  3. Dayenne van Leeuwen (8)
  4. Hollie Pegram (7)
  5. Isabelle Riviere (7)
  6. Kevin Curran (7)

More People

Years
  1. 2022 (1)
  2. 2021 (3)
  3. 2020 (3)
  4. 2019 (2)
  5. 2018 (6)
  6. 2017 (2)

More Years

Publications
  1. Blood (6)
  2. Molecular Therapy (4)
  3. Cytotherapy (3)
  4. Leukemia (2)
  5. Blood Cancer Discovery (1)
  6. Bone Marrow Transplantation (1)

More Publications

Publishers
  1. Nature Publishing Group (9)
  2. American Society of Hematology (6)
  3. American Association for Cancer Research (4)
  4. Elsevier Science Ltd. (3)
  5. American Association for the Advancement of Science (1)
  6. Cell Press (1)

Results (24)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Discovery proteomics for analytes to predict cytokine release syndrome on day of infusion of chimeric antigen receptor (CAR) T cells
    Meeting Abstract

    Lakkaraja, M.; Hosszu, K.; Mcavoy, D.; Mauguen, A.; Purdon, T. J.; Auchincloss, T.; Klein, E.; Khakoo, Y.; Santomasso, B.; Senechal, B.; more...
    Cytotherapy (2022)

    Fulltext@MSK | Save
  • Phase I first-in-class trial of MCARH109, a G protein coupled receptor class C group 5 member D (GPRC5D) targeted CAR T cell therapy in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Mailankody, S.; Diamonte, C.; Fitzgerald, L.; Kane, P.; Wang, X.; Sikder, D. S.; Senechal, B.; Bermudez, V. P.; Frias, D.; Morgan, J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Decreased neuroprotective analytes on day of infusion of chimeric antigen receptor (CAR) T cells are associated with neurotoxicity
    Meeting Abstract

    Lakkaraja, M.; Hosszu, K.; McAvoy, D.; Mauguen, A.; Purdon, T. J.; Khakoo, Y.; Santomasso, B. D.; Riviere, I.; Sadelain, M.; Curran, K. J.; more...
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save
  • Predictors for neurotoxicity on day of infusion of chimeric antigen receptor (CAR) T cells using discovery proteomics platform
    Meeting Abstract

    Lakkaraja, M.; Hosszu, K.; McAvoy, D.; Mauguen, A.; Purdon, T. J.; Auchincloss, T.; Klein, E.; Khakoo, Y.; Santomasso, B.; Senechal, B.; more...
    Cytotherapy (2021)

    Fulltext@MSK | Save
  • Defining an optimal dual-targeted CAR T-cell therapy approach simultaneously targeting BCMA and GPRC5D to prevent BCMA escape– Driven relapse in multiple myeloma
    Journal Article

    de Larrea, C. F.; Staehr, M.; Lopez, A. V.; Ng, K. Y.; Chen, Y.; Godfrey, W. D.; Purdon, T. J.; Ponomarev, V.; Wendel, H. G.; Brentjens, R. J.; more...
    Blood Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages
    Journal Article

    Song, M.; Yeku, O. O.; Rafiq, S.; Purdon, T.; Dong, X.; Zhu, L.; Zhang, T.; Wang, H.; Yu, Z.; Mai, J.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • Engineering armored TCR-modified T cells to enhance anti-tumor efficacy
    Meeting Abstract

    Drakes, D. J.; Rafiq, S.; Purdon, T.; Brentjens, R.
    Cancer Immunology Research (2020)

    Fulltext@MSK | Save
  • Optimal dual-targeted CAR construct simultaneously targeting BCMA and GPRC5D prevents BCMA-escape driven relapse in multiple myeloma
    Meeting Abstract

    Fernandez de Larrea, C.; Staehr, M.; Lopez, A.; Chen, Y.; Purdon, T. J.; Ng, K. Y.; Wendel, H.; Brentjens, R. J.; Smith, E. L.
    Blood (2019)

    Fulltext@MSK | Save
  • GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells
    Journal Article

    Smith, E. L.; Harrington, K.; Staehr, M.; Masakayan, R.; Jones, J.; Long, T. J.; Ng, K. Y.; Ghoddusi, M.; Purdon, T. J.; Wang, X.; more...
    Science Translational Medicine (2019)

    Fulltext@MSK | Save
  • CAR T cells secreting an immune checkpoint blockade scFv have enhanced anti-tumor efficacy
    Meeting Abstract

    Rafiq, S.; Yeku, O.; Jackson, H.; Purdon, T.; van Leeuwen, D.; Yan, S.; Wang, P.; Xiang, J.; Liu, C.; Seshan, V.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save